Bone Biologics Co. (NASDAQ:BBLGW) Short Interest Up 44.4% in April

Bone Biologics Co. (NASDAQ:BBLGW) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,300 shares, a growth of 44.4% from the March 31st total of 900 shares. Based on an average daily volume of 1,800 shares, the days-to-cover ratio is currently 0.7 days.

Bone Biologics Price Performance

Shares of Bone Biologics stock traded down $1.04 during trading on Friday, hitting $22.00. 1,654 shares of the company were exchanged, compared to its average volume of 2,960. The firm’s fifty day moving average price is $15.46 and its 200 day moving average price is $8.44. Bone Biologics has a 1-year low of $0.43 and a 1-year high of $44.15.

About Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.